Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Dermatology
•
Drug Eruptions
How do you approach monitoring in DRESS or DiHS patients?
Which tests do you order and when do you re-order tests?
Related Questions
After corticosteroids, what second line agent do you select to treat drug induced hypersensitivity syndrome (also known as DRESS syndrome)?
What treatment would you offer a patient with extensive lymphangioma circumscriptum intermittently covering the entire abdomen?
How soon after excising a keloid do you inject kenalog?
What is your workup algorithm for adult patients with cutaneous biopsy-proven Langerhans cell histiocytosis?
Have you utilized JAK inhibitors in patients on dialysis?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
How often have you found patients complain about an infusion reaction to Remicade?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
How would you manage a patient with Takayasu arteritis controlled on TNFi who develops erythema nodosum that is only partially responsive to NSAIDs?
